Former Health Canada Inspector Dr. Sherry Boodram Joins Nextleaf Solutions Board Of Directors
Nextleaf Solutions, a leading cannabis extraction technology company, has announced today that it has added Dr. Sherry Boodram, former Senior Regulatory Compliance Officer with Health Canada, to its Board of Directors, effective immediately.
Dr. Sherry Boodram worked for the Canadian federal government for several years and was responsible for licensing application reviews and on-site facility inspections of Canadian cannabis industry facilities.
Dr. Boodram also provided field level input during the drafting of the current Canadian cannabis regulations.
“Being a company with values I can stand behind, I’m very excited to serve alongside Nextleaf’s existing Board members and with their talented executive team,” stated Dr. Sherry Boodram. “Moreover, I look forward to maximizing the unique knowledge and experience I gained while at Health Canada’s Medical Cannabis Program, and in the cannabis industry as a whole, to provide expertise in support of Nextleaf’s ongoing commitment to regulatory compliance, good governance, and long-term growth as a leader in cannabis extraction technology.”
Dr. Boodram holds a Ph.D. in Chemistry from York University, a B.Sc. (Hon) from the University of Toronto, and a Graduate Certificate with Honours in Pharmaceutical Regulatory Affairs and Quality Operations from Seneca College. Dr. Boodram is also a member of the Canadian Association of Professionals in Regulatory Affairs (CAPRA).
Currently, Dr. Boodram is the co-founder and CEO of CannDelta Inc. (“CannDelta”) – a regulatory and scientific cannabis consulting company based out of Toronto, Canada – where she provides regulatory expertise and develops strategies to ensure regulatory compliance within Canada’s existing legal cannabis framework.
“The serious regulatory infractions by several large Canadian licensed cannabis producers, along with an expanded scope of cannabis products through legalization 2.0, reinforces the critical role that compliance oversight plays in building a cannabis company all stakeholders can be proud of,” stated Paul Pedersen, co-founder and CEO of Nextleaf Solutions. “Sherry is amongst the most credible and qualified cannabis regulatory experts in Canada, and we believe her background, insights, and industry experience will add tremendous value to our Board.”
About Nextleaf Solutions
Nextleaf Solutions Ltd. (“OILS”) is developing disruptive intellectual property for industrial-scale extraction, purification, and formulation of cannabinoids. OILS owns a portfolio of eight (8) issued and 35 pending patents pertaining to the production of high-purity, cannabinoid-rich distillate, the key ingredient used in the manufacturing of standardized THC and CBD infused products. Once cannabis concentrates and edibles become legal across Canada, OILS plans to commercialize its intellectual property portfolio through IP licensing, B2B processing services, and the supply of THC and CBD oils and concentrates to qualified Canadian and international partners.
Nextleaf Solutions trades as OILS on the Canadian Securities Exchange (CSE: OILS), OILFF on the OTCQB Market in the United States (OTCQB: OILFF) and L0MA on the Frankfurt Stock Exchange (FSE: L0MA).